Rifaximin (Compound)

Synonyms:Rifaximin, Rifaxidin, Rifacol, Xifaxan, 80621-81-4, Rifaximine, Rifamycin L 105, Rifamycin L 105SV, Fatroximin, Normix, Rifaximina, C43H51N3O11, Rifamixin, Rifaximine [French], Rifaximinum [Latin], Rifaximina [Spanish], UNII-L36O5T016N, Ritacol, CHEBI:75246, L36O5T016N, MFCD00864973, Rifaximin (Xifaxan), Rifaximinum, 4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4-c)rifamycin SV, BRN 3584528, (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-1,15-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)furo[2'',3'':7',8']naphtho[1',2':4,5]imidazo[1,2-a]pyridin-25-yl acetate, Rifaxin, RedActiv, (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-25-(Acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)benzofuro[4,5-e]pyrido[1,2-a]benzimidazole-1,15(2H)-dione, L 105SV, L 105 (Ansamacrolide antibiotic), L 105, rifaximinun, Flonorm, Lumenax, Spiraxin, Xifaxsan, Lormyx, Rifaximin [USAN:INN:BAN], 4-Deoxy-4'-methylpyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV, 5-yl acetate, NCGC00095842-01, Xifaxan (TN), alpha-0817185, CHEMBL1617, DSSTox_CID_25998, DSSTox_RID_81280, DSSTox_GSID_45998, (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26S,27S,28E)-5,6,21,23,25 Pentahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-2,7-(epoxypentadeca(1,11,13)trienimino)benzofuro(4,5-e)pyrido(1,2-a)benzimidazole-1,15(2H)-dione, 25-acetate, Rifaximin (JAN/USAN/INN), SCHEMBL124066, DTXSID7045998, HMS3715B19, 88747-56-2, Tox21_111529, BDBM50347620, s1790, AKOS015963053, ZINC169621200, CCG-221129, DB01220, NSC 758957, ido[1,2-a]benzimidazol-25-yl acetate, 2,7-(Epoxy(1,11,13)pentadecatrienoimino)furo(2'',3'':7',8')naphth(1',2':4,5)imidazo(1,2-a)pyridine-1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, ( 2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-, 2,7-(Epoxypentadeca(1,11,13)trienimino)benzofuro(4,5-e)pyrido(1,2-a)benzimidazole-1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, (2S-(2R*,16Z,18E,20R*,21R*,22S*,23S*,24S*,25R*,26S*,27R*,28E))-, AC-19112, H732, CAS-80621-81-4, D02554, J10371, AB01209738-01, AB01209738-03, AB01209738_04, Rifaximin, Antibiotic for Culture Media Use Only, 621R814, Q416073, Q-201671, (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-1,1, (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)5,6,21,23-Tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-1,15-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)[1]benzofuro[4,5-e]pyr, (7S,11S,12R,13S,14R,15R,16R,17S,18S)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.1^{4,7}.0^{5,35}.0^{26,34}.0^{27,32}]heptatriaconta-1,3,5(35),9,19,21,25(36),26(34),28,30,32-undecaen-13-yl acetate, 5-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)furo[2'',3'':7',8']naphtho[1',2':4,5]imidazo[1,2-a]pyridin-2
Pubchem:PUBCHEM:6436173
Id:0d830689-a1bf-58c2-a083-e5c56200d01a
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Rifaximin's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Rifaximin.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Rifaximin.

Results found

Linked to

 

Label

Description

 

Collection

DrugPage Collection: (DrugCentralID:02379; PubChem_CID:6436173, FILE=drugcentral_drug_02379.json)

Collection

Metadatata for rifaximin

Knowledge Graph Assertion

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.